Total Payments
$56,230
2023 Payments
$12,204
Companies
9
Transactions
79
Payment Breakdown by Category
Consulting$35,510 (63.2%)
Travel$10,067 (17.9%)
Research$5,635 (10.0%)
Other$2,645 (4.7%)
Food & Beverage$2,372 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,510 | 8 | 63.2% |
| Travel and Lodging | $10,067 | 33 | 17.9% |
| Unspecified | $5,635 | 2 | 10.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,645 | 1 | 4.7% |
| Food and Beverage | $2,372 | 35 | 4.2% |
Payments by Type
General
$50,595
77 transactions
Research
$5,635
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $25,552 | 46 | $0 (2019) |
| VBI Vaccine (Delaware) Inc. | $9,375 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $6,930 | 8 | $0 (2018) |
| Saol Therapeutics Inc. | $6,000 | 2 | $0 (2022) |
| ModernaTX, Inc. | $2,829 | 9 | $0 (2023) |
| Roche Diagnostics Corporation | $2,645 | 1 | $0 (2022) |
| SANOFI PASTEUR INC. | $1,676 | 10 | $0 (2019) |
| Janssen Research & Development, LLC | $1,210 | 1 | $0 (2022) |
| Meridian Bioscience Inc. | $11.70 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $12,204 | 10 | VBI Vaccine (Delaware) Inc. ($9,375) |
| 2022 | $8,655 | 3 | Saol Therapeutics Inc. ($4,800) |
| 2020 | $1,200 | 1 | Saol Therapeutics Inc. ($1,200) |
| 2019 | $5,951 | 12 | Merck Sharp & Dohme Corporation ($4,275) |
| 2018 | $21,415 | 38 | Merck Sharp & Dohme Corporation ($14,474) |
| 2017 | $6,804 | 15 | Merck Sharp & Dohme Corporation ($6,804) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $589.80 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $571.79 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $534.54 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $352.01 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $206.72 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $199.29 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $174.93 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $132.00 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $68.28 | General |
| 05/24/2023 | VBI Vaccine (Delaware) Inc. | PreHevbrio (Drug) | Consulting Fee | Cash or cash equivalent | $9,375.00 | General |
| Category: VACCINES | ||||||
| 06/15/2022 | Roche Diagnostics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,645.00 | General |
| Category: None | ||||||
| 03/24/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,210.00 | General |
| 01/19/2022 | Saol Therapeutics Inc. | Cytogam (Drug) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Cytomegalovirus | ||||||
| 11/12/2020 | Saol Therapeutics Inc. | Cytogam (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Cytomegalovirus | ||||||
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $680.29 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $383.88 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $378.00 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $49.00 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| 03/26/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| 03/07/2019 | Merck Sharp & Dohme Corporation | V160 (Biological) | Consulting Fee | Cash or cash equivalent | $4,125.00 | General |
| Category: VACCINE | ||||||
About Dr. Mark Schleiss, MD
Dr. Mark Schleiss, MD is a Pediatrics healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942382452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Schleiss, MD has received a total of $56,230 in payments from pharmaceutical and medical device companies, with $12,204 received in 2023. These payments were reported across 79 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($35,510).
Ad
Practice Information
- Specialty Pediatrics
- Location Minneapolis, MN
- Active Since 10/20/2006
- Last Updated 04/18/2012
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1942382452
Products in Payments
- PreHevbrio (Drug) $9,375
- Cytogam (Drug) $6,000
- PREVYMIS (Drug) $5,712
- V160 (Biological) $4,275
- NO PRODUCT DISCUSSED (Drug) $1,676
- ZINPLAVA (Biological) $557.00
- ZINPLAVA (Drug) $535.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Minneapolis
Dr. Bruce Blazar, M.d, M.D
Pediatrics — Payments: $1.1M
Pediatrics $1.1M
Bradley Miller, M.d, M.D
Pediatrics — Payments: $567,210
Pediatrics $567,210
Kyriakie Sarafoglou, Md, MD
Pediatrics — Payments: $368,453
Pediatrics $368,453
Dr. Sheldon Mauer, Md, MD
Pediatrics — Payments: $175,979
Pediatrics $175,979
Heather Stefanski, Md, Ph.d, MD, PH.D
Pediatrics — Payments: $159,475
Pediatrics $159,475
Antoinette Moran, M.d, M.D
Pediatrics — Payments: $98,422
Pediatrics $98,422